Anthony Van den Pol, a professor of Neurosurgery at Yale University recently published research along with a team of other researchers about getting rid of brain tumours with a hybrid version of Ebola virus, Ebola VSV, in the journal.
The research work is titled, “Mucin-like domain of Ebola virus glycoprotein enhances selective oncolytic actions against brain tumours.”
Ebola VSV, (rVSV – ZEBOV Vaccine, is a vaccine that prevents Ebola virus) has shown to be highly effective on vaccinated subjects. The treated Ebola virus has also shown to be very effective in treating Glioblastoma (an aggressive form of cancer that can infect either the brain or the spine), in mice.
According to Anthony Van den Pol, the lead researcher, if this researcher is eventually successful, then one of the deadliest diseases known to man will be used to cure one of the most dangerous types of spinal/brain cancer.
A little under 100,000 cases of Glioblastoma are recorded in Nigeria annually.
After diagnosis, a patient can live for an average of 14 months/2 years with proper treatment. Without proper treatment, a patient will have a considerably shorter time to live.